Compare Destinasi Tirta Nusantara Tbk (PDES) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Destinasi Tirta Nusantara Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Destinasi Tirta Nusantara Tbk trades at Rp384 (market cap 275.99B, 77.3K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Destinasi Tirta Nusantara Tbk is far larger — about 2.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PDES | SCPI | |
|---|---|---|
Market Cap | 275.99B | 104.4B |
Volume | 77.3K | — |
Lot | 773 | — |
Turnover | 29.21M | — |
Average Price | 377.92 | — |
Value | 29.21M | — |
Indicative Equilibrium Price | 384 | — |
Indicative Equilibrium Volume | 200 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Destinasi Tirta Nusantara Tbk
PT Destinasi Tirta Nusantara Tbk (the company) was established on 30 Oct 1999 based on Notaries Deed No. 36 and the deed of establishment was approved by the the Ministry of Justice dated Feb 23, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 187 and No.136 of Wijanto Suwongso, S.H., dated Jun 28, 2007 and 24 Oct 07, concerning among others, increase authorized, Paid up Capital, par value and public offering.
Read more on PDES →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
